Dr. Rousseau has served as Milestone’s Vice President of Regulatory Affairs and Quality Assurance since 2016 with responsibilities to lead global regulatory affairs. Dr. Rousseau brings over 30 years of international experience in regulatory affairs and in global drug development.
Mr. Pimplaskar has served as Milestone’s Vice President of Chemistry, Manufacturing and Controls since 2018. He brings 25 years of experience in CMC, pharmaceutical development, clinical manufacturing and technology transfer to his role as head of CMC for global drug development of Milestone’s cardiovascular programs.
Mr. Hasija joined Milestone as Chief Financial Officer in September 2019. Prior to Milestone Pharmaceuticals, Mr. Hasija served as Chief Financial Officer and Chief Business Officer at Fulcrum Therapeutics, a publicly traded, clinical-stage biopharmaceutical company focused on developing therapies for genetically defined rare diseases.